Recent advances in pharmaceutical dosage forms and devices using additive manufacturing technologies

CI Gioumouxouzis, C Karavasili, DG Fatouros - Drug discovery today, 2019 - Elsevier
Highlights•3DP has the potential to revolutionize personalized therapy.•Rapid increase in
3PD formulations reported during past 5 years.•Potential for cost-effective production of …

Stereolithography 3D printing technology in pharmaceuticals: a review

S Deshmane, P Kendre, H Mahajan… - Drug Development and …, 2021 - Taylor & Francis
Abstract Three-dimensional printing (3DP) technology is an innovative tool used in
manufacturing medical devices, producing alloys, replacing biological tissues, producing …

Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment

AE Massey, M Sikander, N Chauhan, S Kumari… - … , Biology and Medicine, 2019 - Elsevier
Pancreatic cancer (PanCa) is a major cause of cancer-related death due to limited
therapeutic options. As pancreatic tumors are highly desmoplastic, they prevent appropriate …

Impairment of electron transport chain and induction of apoptosis by chrysin nanoparticles targeting succinate-ubiquinone oxidoreductase in pancreatic and lung …

EM Ragab, DM El Gamal, TM Mohamed, AA Khamis - Genes & Nutrition, 2023 - Springer
Background Flavonoids may help ameliorate the incidence of the major causes of tumor-
related mortality, such as pancreatic ductal adenocarcinoma (PDAC) and lung cancer, which …

Application of three-dimensional printing technology in renal diseases

S Dai, Q Wang, Z Jiang, C Liu, X Teng, S Yan… - Frontiers in …, 2022 - frontiersin.org
Three-dimensional (3D) printing technology involves the application of digital models to
create 3D objects. It is used in construction and manufacturing and has gradually spread to …

Synergistic effect of a drug loaded electrospun patch and systemic chemotherapy in pancreatic cancer xenograft

E Jun, SC Kim, CM Lee, J Oh, S Lee, IK Shim - Scientific reports, 2017 - nature.com
Pancreatic cancer has a high rate of local recurrence and poor prognosis even with adjuvant
chemotherapy after curative resection. The aim of this study was to investigate if local drug …

Dauricine suppresses the growth of pancreatic cancer in vivo by modulating the Hedgehog signaling pathway

YB Zhang, HX Fei, J Guo, XJ Zhang… - Oncology …, 2019 - spandidos-publications.com
Pancreatic cancer is a highly malignant cancer associated with high expression levels of
sonic hedgehog signaling molecule (Shh), patched 1 (Ptch1), smoothened frizzled class …

[HTML][HTML] Research progress of 3D-bioprinted functional pancreas and in vitro tumor models

L Wu, H Li, Y Liu, Z Fan, J Xu, N Li, X Qian… - … Journal of Bioprinting, 2024 - accscience.com
With the rapid development of three-dimensional (3D) bioprinting technology, the research
revolving around in vitro functional pancreas and tumor models has become the focus of …

Advanced fabrication approaches to controlled delivery systems for epilepsy treatment

GS van Tienderen, M Berthel, Z Yue… - Expert Opinion on …, 2018 - Taylor & Francis
Introduction: Epilepsy is a chronic brain disease characterized by unprovoked seizures,
which can have severe consequences including loss of awareness and death. Currently …

The reversible reproductive toxicity of 5-fluorouracil in mice

G Naren, L Wang, X Zhang, L Cheng, S Yang… - Reproductive …, 2021 - Elsevier
Fluorouracil (5-FU) is a “cytotoxic” drug used for cancer chemotherapy, which inhibits cells
division via affecting DNA synthesis. Although being widely used for cancer treatment, 5-FU …